- Trials with a EudraCT protocol (1,691)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,691 result(s) found for: Understanding.
Displaying page 1 of 85.
| EudraCT Number: 2009-011248-21 | Sponsor Protocol Number: | Start Date*: 2009-06-29 |
| Sponsor Name: | ||
| Full Title: het optimaliseren van de voorbereiding voor sigmoidoscopie in de regio; Moviprep versus Bisacodyl/klysma, een enkelblind gerandomiseerd onderzoek | ||
| Medical condition: Bowel preparation for sigmoidoscopy. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012372-27 | Sponsor Protocol Number: 200901 | Start Date*: 2009-09-17 | |||||||||||
| Sponsor Name:LUMC | |||||||||||||
| Full Title: The Sevoflurane study, understanding the effects of Sevoflurane to improve safety and outcome of cardiac surgery | |||||||||||||
| Medical condition: myocardial ischemia reperfusion injury during cardiac surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-000683-30 | Sponsor Protocol Number: CoVacc | Start Date*: 2021-03-03 |
| Sponsor Name:Umeå university | ||
| Full Title: CoVacc - Immune response to vaccination against Covid-19, an open multicenter phase IV study | ||
| Medical condition: Individuals with and without pre-existing immunity to Covid-19. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005113-73 | Sponsor Protocol Number: 20150114 | Start Date*: 2016-07-01 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation | ||
| Medical condition: Type 2 diabetes with albuminuria | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006713-25 | Sponsor Protocol Number: ASSENTE | Start Date*: 2008-09-23 |
| Sponsor Name:OSPEDALE MAGGIORE DI MILANO (IRCCS) | ||
| Full Title: A SINGLE-ARM PILOT STUDY WITH LOW-DOSE RITUXIMAB PLUS STANDARD ORAL PREDNISONE IN IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA | ||
| Medical condition: ANEMIE EMOLITICHE AUTOIMMUNI IDIOPATICHE | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002230-41 | Sponsor Protocol Number: PPH-LYF02 | Start Date*: 2015-06-29 |
| Sponsor Name:Landspitali University Hospital | ||
| Full Title: Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic Population. | ||
| Medical condition: Gastro Oesophageal Reflux Disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IS (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-003133-33 | Sponsor Protocol Number: EMG-2006 | Start Date*: 2006-07-14 |
| Sponsor Name:Hôpital Erasme | ||
| Full Title: Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe. | ||
| Medical condition: healthy subjects obstructive sleep apnea (Bosentan is used in clinic in pulmonary hypertension) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-016911-39 | Sponsor Protocol Number: 113954 | Start Date*: 2010-05-05 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: An open, phase IV, multicentre, study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B vaccine challenge in healthy children aged 11-12... | ||
| Medical condition: Antibody persistence and hepatitis B vaccine challenge at 11-12 years of age (excluding 13th birthday), after primary vaccination with GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) or G... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: SK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-000728-24 | Sponsor Protocol Number: MEBENDAZOLGAI3003 | Start Date*: 2016-03-01 |
| Sponsor Name: Janssen Research & Development, LLC | ||
| Full Title: A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of a 500-mg Chewable Tablet of Mebendazole in the Treatment o... | ||
| Medical condition: Helminth infections | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2018-003083-30 | Sponsor Protocol Number: PLAQHV | Start Date*: 2019-01-31 | |||||||||||
| Sponsor Name:UZ Leuven | |||||||||||||
| Full Title: The effect of hydroxychloroquine sulphate on hedonic food intake, appetite-related sensations and gastrointestinal hormone release in healthy female subjects | |||||||||||||
| Medical condition: The study is meant to have a better understanding in obesity and how we can prevent/cure it. Therefore, the product will first be tested in healthy, lean volunteers. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-005534-36 | Sponsor Protocol Number: Scope | Start Date*: 2008-02-04 |
| Sponsor Name:King's College Hospital [...] | ||
| Full Title: The effect of Exenatide on satiety, metabolic parameters and regional brain activation in response to nutrient ingestion in Type 2 diabetes. | ||
| Medical condition: The brainﾒs response to food ingestion can be imaged and preliminary data suggest that these responses are different in the obese and insulin resistant. We will investigate the hypothesis that Exen... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-001779-35 | Sponsor Protocol Number: 4 | Start Date*: 2013-02-15 | |||||||||||
| Sponsor Name:University of Southampton | |||||||||||||
| Full Title: The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder | |||||||||||||
| Medical condition: Generalised anxiety disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-002909-10 | Sponsor Protocol Number: P137 | Start Date*: 2022-10-24 |
| Sponsor Name:Maastricht University | ||
| Full Title: THE IMPACT OF PSILOCYBIN ON PAIN IN FIBROMYALGIA PATIENTS AND HEALTHY VOLUNTEERS: A MULTICENTER TRIAL | ||
| Medical condition: Fibromyalgia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002161-56 | Sponsor Protocol Number: NeM-CSM-FT-01 | Start Date*: 2017-04-13 |
| Sponsor Name:Mateusz Gola | ||
| Full Title: Towards the understanding of neuronal mechanisms of compulsive sexual behaviors - pharmacotherapy | ||
| Medical condition: compulsive sexual behavior (hypersexual disorder) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: PL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001877-34 | Sponsor Protocol Number: HOT-Treated | Start Date*: 2016-11-25 | |||||||||||||||||||||
| Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | |||||||||||||||||||||||
| Full Title: Improving understanding of Heroin Overdose Testing: diamorphine dose-escalation testing in a treated population | |||||||||||||||||||||||
| Medical condition: Opioid Overdose | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2006-001509-26 | Sponsor Protocol Number: DESG-01 | Start Date*: 2006-10-11 |
| Sponsor Name:Dermal Laboratories Limited | ||
| Full Title: An open evaluation of an emollient shower gel for dry skin conditions. | ||
| Medical condition: Dry or chapped skin conditions which may also be pruritic (itchy) or inflamed e.g. eczema, psoriasis, elderly pruritus and dermatitis. | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003854-80 | Sponsor Protocol Number: 02B2005 | Start Date*: 2006-01-31 |
| Sponsor Name:Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University | ||
| Full Title: Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral versus Central | ||
| Medical condition: Patients with osteoarthritis undergoing elective primary single hip arthroplasty | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004735-37 | Sponsor Protocol Number: NL60549.078.17 | Start Date*: 2018-03-05 |
| Sponsor Name:Erasmus University Rotterdam | ||
| Full Title: Can Acetaminophen Ease the Heartbreak of Social Rejection? | ||
| Medical condition: Healthy participants | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005194-30 | Sponsor Protocol Number: P-AD337-021 | Start Date*: 2006-06-12 |
| Sponsor Name:Arakis Ltd. | ||
| Full Title: A multi-centre, randomised, double-blind, placebo controlled, parallel group exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the treatment of fibromyalgia in fem... | ||
| Medical condition: Fibromyalgia | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001131-30 | Sponsor Protocol Number: EZ-2053-001 | Start Date*: 2005-07-22 |
| Sponsor Name:Fresenius Biotech North America | ||
| Full Title: A Double-Blind, Placebo-Controlled, Multicenter, Dose-ranging Study of an Anti-T-lymphocyte Immunglobuline (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of... | ||
| Medical condition: Patients with end-stage pulmonary failure, who are receiving a primary single or double pulmonary allograft | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
